nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Ezetimibe—atherosclerosis	0.125	0.267	CbGbCtD
Scopolamine—ABCB1—Simvastatin—atherosclerosis	0.116	0.248	CbGbCtD
Scopolamine—ABCB1—Lovastatin—atherosclerosis	0.114	0.243	CbGbCtD
Scopolamine—ABCB1—Pravastatin—atherosclerosis	0.114	0.243	CbGbCtD
Scopolamine—Redness—Niacin—atherosclerosis	0.00694	0.0238	CcSEcCtD
Scopolamine—Amblyopia—Niacin—atherosclerosis	0.00606	0.0208	CcSEcCtD
Scopolamine—Amnesia—Rosuvastatin—atherosclerosis	0.00497	0.0171	CcSEcCtD
Scopolamine—Amnesia—Lovastatin—atherosclerosis	0.00421	0.0145	CcSEcCtD
Scopolamine—Amnesia—Ezetimibe—atherosclerosis	0.00413	0.0142	CcSEcCtD
Scopolamine—Eczema—Simvastatin—atherosclerosis	0.00412	0.0142	CcSEcCtD
Scopolamine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00412	0.0142	CcSEcCtD
Scopolamine—Amnesia—Simvastatin—atherosclerosis	0.00394	0.0135	CcSEcCtD
Scopolamine—Eczema—Niacin—atherosclerosis	0.00378	0.013	CcSEcCtD
Scopolamine—Amnesia—Pravastatin—atherosclerosis	0.00356	0.0122	CcSEcCtD
Scopolamine—Muscular weakness—Ezetimibe—atherosclerosis	0.00342	0.0118	CcSEcCtD
Scopolamine—Muscular weakness—Simvastatin—atherosclerosis	0.00326	0.0112	CcSEcCtD
Scopolamine—Urinary retention—Niacin—atherosclerosis	0.00323	0.0111	CcSEcCtD
Scopolamine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00321	0.011	CcSEcCtD
Scopolamine—Dry skin—Niacin—atherosclerosis	0.00312	0.0107	CcSEcCtD
Scopolamine—Dry skin—Pravastatin—atherosclerosis	0.00307	0.0105	CcSEcCtD
Scopolamine—Muscular weakness—Niacin—atherosclerosis	0.003	0.0103	CcSEcCtD
Scopolamine—Muscular weakness—Pravastatin—atherosclerosis	0.00295	0.0101	CcSEcCtD
Scopolamine—Dysphagia—Niacin—atherosclerosis	0.00294	0.0101	CcSEcCtD
Scopolamine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00289	0.00992	CcSEcCtD
Scopolamine—Mental disorder—Rosuvastatin—atherosclerosis	0.00283	0.00973	CcSEcCtD
Scopolamine—Dysuria—Pravastatin—atherosclerosis	0.0027	0.0093	CcSEcCtD
Scopolamine—Pharyngitis—Ezetimibe—atherosclerosis	0.00266	0.00916	CcSEcCtD
Scopolamine—Flushing—Lovastatin—atherosclerosis	0.00254	0.00873	CcSEcCtD
Scopolamine—Sweating—Niacin—atherosclerosis	0.00251	0.00863	CcSEcCtD
Scopolamine—Flushing—Ezetimibe—atherosclerosis	0.00249	0.00857	CcSEcCtD
Scopolamine—Flushing—Simvastatin—atherosclerosis	0.00238	0.00817	CcSEcCtD
Scopolamine—Mental disorder—Ezetimibe—atherosclerosis	0.00235	0.00809	CcSEcCtD
Scopolamine—Erythema—Ezetimibe—atherosclerosis	0.00234	0.00804	CcSEcCtD
Scopolamine—Confusional state—Rosuvastatin—atherosclerosis	0.00231	0.00795	CcSEcCtD
Scopolamine—Pharyngitis—Pravastatin—atherosclerosis	0.0023	0.0079	CcSEcCtD
Scopolamine—Visual impairment—Niacin—atherosclerosis	0.00227	0.00779	CcSEcCtD
Scopolamine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00225	0.00774	CcSEcCtD
Scopolamine—Vision blurred—Lovastatin—atherosclerosis	0.00225	0.00772	CcSEcCtD
Scopolamine—Mental disorder—Simvastatin—atherosclerosis	0.00224	0.00771	CcSEcCtD
Scopolamine—Tremor—Lovastatin—atherosclerosis	0.00223	0.00768	CcSEcCtD
Scopolamine—Visual impairment—Pravastatin—atherosclerosis	0.00223	0.00767	CcSEcCtD
Scopolamine—Erythema—Simvastatin—atherosclerosis	0.00223	0.00766	CcSEcCtD
Scopolamine—Eye disorder—Niacin—atherosclerosis	0.0022	0.00755	CcSEcCtD
Scopolamine—Flushing—Niacin—atherosclerosis	0.00218	0.0075	CcSEcCtD
Scopolamine—Flushing—Pravastatin—atherosclerosis	0.00215	0.00739	CcSEcCtD
Scopolamine—Vertigo—Lovastatin—atherosclerosis	0.00214	0.00736	CcSEcCtD
Scopolamine—Vision blurred—Simvastatin—atherosclerosis	0.0021	0.00722	CcSEcCtD
Scopolamine—Arrhythmia—Niacin—atherosclerosis	0.0021	0.00722	CcSEcCtD
Scopolamine—Tremor—Simvastatin—atherosclerosis	0.00209	0.00718	CcSEcCtD
Scopolamine—Arrhythmia—Pravastatin—atherosclerosis	0.00207	0.00711	CcSEcCtD
Scopolamine—Erythema—Niacin—atherosclerosis	0.00205	0.00704	CcSEcCtD
Scopolamine—Vertigo—Simvastatin—atherosclerosis	0.002	0.00688	CcSEcCtD
Scopolamine—Dry mouth—Lovastatin—atherosclerosis	0.00198	0.00682	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00198	0.00679	CcSEcCtD
Scopolamine—Constipation—Rosuvastatin—atherosclerosis	0.00196	0.00675	CcSEcCtD
Scopolamine—Pain—Rosuvastatin—atherosclerosis	0.00196	0.00675	CcSEcCtD
Scopolamine—Confusional state—Lovastatin—atherosclerosis	0.00196	0.00674	CcSEcCtD
Scopolamine—Dry mouth—Ezetimibe—atherosclerosis	0.00195	0.00669	CcSEcCtD
Scopolamine—Vision blurred—Niacin—atherosclerosis	0.00193	0.00663	CcSEcCtD
Scopolamine—Confusional state—Ezetimibe—atherosclerosis	0.00192	0.00661	CcSEcCtD
Scopolamine—Vision blurred—Pravastatin—atherosclerosis	0.0019	0.00653	CcSEcCtD
Scopolamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00189	0.0065	CcSEcCtD
Scopolamine—Tremor—Pravastatin—atherosclerosis	0.00189	0.00649	CcSEcCtD
Scopolamine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00187	0.00643	CcSEcCtD
Scopolamine—Skin disorder—Ezetimibe—atherosclerosis	0.00185	0.00637	CcSEcCtD
Scopolamine—Vertigo—Niacin—atherosclerosis	0.00184	0.00632	CcSEcCtD
Scopolamine—Confusional state—Simvastatin—atherosclerosis	0.00183	0.00631	CcSEcCtD
Scopolamine—Oedema—Simvastatin—atherosclerosis	0.00182	0.00625	CcSEcCtD
Scopolamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00181	0.00624	CcSEcCtD
Scopolamine—Vertigo—Pravastatin—atherosclerosis	0.00181	0.00622	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00173	0.00595	CcSEcCtD
Scopolamine—Dry mouth—Niacin—atherosclerosis	0.0017	0.00586	CcSEcCtD
Scopolamine—Fatigue—Lovastatin—atherosclerosis	0.00168	0.00576	CcSEcCtD
Scopolamine—Oedema—Niacin—atherosclerosis	0.00167	0.00574	CcSEcCtD
Scopolamine—Constipation—Lovastatin—atherosclerosis	0.00166	0.00572	CcSEcCtD
Scopolamine—Pain—Lovastatin—atherosclerosis	0.00166	0.00572	CcSEcCtD
Scopolamine—Confusional state—Pravastatin—atherosclerosis	0.00166	0.0057	CcSEcCtD
Scopolamine—Asthenia—Rosuvastatin—atherosclerosis	0.00165	0.00566	CcSEcCtD
Scopolamine—Oedema—Pravastatin—atherosclerosis	0.00164	0.00565	CcSEcCtD
Scopolamine—Fatigue—Ezetimibe—atherosclerosis	0.00164	0.00565	CcSEcCtD
Scopolamine—Pain—Ezetimibe—atherosclerosis	0.00163	0.00561	CcSEcCtD
Scopolamine—Constipation—Ezetimibe—atherosclerosis	0.00163	0.00561	CcSEcCtD
Scopolamine—Tachycardia—Niacin—atherosclerosis	0.00163	0.0056	CcSEcCtD
Scopolamine—Pruritus—Rosuvastatin—atherosclerosis	0.00162	0.00558	CcSEcCtD
Scopolamine—Skin disorder—Niacin—atherosclerosis	0.00162	0.00558	CcSEcCtD
Scopolamine—Hyperhidrosis—Niacin—atherosclerosis	0.00161	0.00555	CcSEcCtD
Scopolamine—Feeling abnormal—Lovastatin—atherosclerosis	0.0016	0.00551	CcSEcCtD
Scopolamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00159	0.00547	CcSEcCtD
Scopolamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00157	0.0054	CcSEcCtD
Scopolamine—Fatigue—Simvastatin—atherosclerosis	0.00157	0.00539	CcSEcCtD
Scopolamine—Hypotension—Niacin—atherosclerosis	0.00156	0.00537	CcSEcCtD
Scopolamine—Constipation—Simvastatin—atherosclerosis	0.00156	0.00535	CcSEcCtD
Scopolamine—Pain—Simvastatin—atherosclerosis	0.00156	0.00535	CcSEcCtD
Scopolamine—Abdominal pain—Lovastatin—atherosclerosis	0.00154	0.00529	CcSEcCtD
Scopolamine—Body temperature increased—Lovastatin—atherosclerosis	0.00154	0.00529	CcSEcCtD
Scopolamine—Dizziness—Rosuvastatin—atherosclerosis	0.00152	0.00522	CcSEcCtD
Scopolamine—Abdominal pain—Ezetimibe—atherosclerosis	0.00151	0.00518	CcSEcCtD
Scopolamine—Body temperature increased—Ezetimibe—atherosclerosis	0.00151	0.00518	CcSEcCtD
Scopolamine—Feeling abnormal—Simvastatin—atherosclerosis	0.0015	0.00515	CcSEcCtD
Scopolamine—Somnolence—Niacin—atherosclerosis	0.00149	0.0051	CcSEcCtD
Scopolamine—Rash—Rosuvastatin—atherosclerosis	0.00145	0.00497	CcSEcCtD
Scopolamine—Dermatitis—Rosuvastatin—atherosclerosis	0.00145	0.00497	CcSEcCtD
Scopolamine—Abdominal pain—Simvastatin—atherosclerosis	0.00144	0.00494	CcSEcCtD
Scopolamine—Body temperature increased—Simvastatin—atherosclerosis	0.00144	0.00494	CcSEcCtD
Scopolamine—Headache—Rosuvastatin—atherosclerosis	0.00144	0.00494	CcSEcCtD
Scopolamine—Pain—Niacin—atherosclerosis	0.00143	0.00491	CcSEcCtD
Scopolamine—Fatigue—Pravastatin—atherosclerosis	0.00142	0.00487	CcSEcCtD
Scopolamine—Pain—Pravastatin—atherosclerosis	0.00141	0.00483	CcSEcCtD
Scopolamine—Constipation—Pravastatin—atherosclerosis	0.00141	0.00483	CcSEcCtD
Scopolamine—Asthenia—Lovastatin—atherosclerosis	0.0014	0.0048	CcSEcCtD
Scopolamine—Pruritus—Lovastatin—atherosclerosis	0.00138	0.00473	CcSEcCtD
Scopolamine—Asthenia—Ezetimibe—atherosclerosis	0.00137	0.00471	CcSEcCtD
Scopolamine—Nausea—Rosuvastatin—atherosclerosis	0.00136	0.00469	CcSEcCtD
Scopolamine—Feeling abnormal—Pravastatin—atherosclerosis	0.00136	0.00466	CcSEcCtD
Scopolamine—Pruritus—Ezetimibe—atherosclerosis	0.00135	0.00464	CcSEcCtD
Scopolamine—Abdominal pain—Niacin—atherosclerosis	0.00132	0.00454	CcSEcCtD
Scopolamine—Body temperature increased—Niacin—atherosclerosis	0.00132	0.00454	CcSEcCtD
Scopolamine—Asthenia—Simvastatin—atherosclerosis	0.00131	0.00449	CcSEcCtD
Scopolamine—Body temperature increased—Pravastatin—atherosclerosis	0.0013	0.00447	CcSEcCtD
Scopolamine—Abdominal pain—Pravastatin—atherosclerosis	0.0013	0.00447	CcSEcCtD
Scopolamine—Pruritus—Simvastatin—atherosclerosis	0.00129	0.00442	CcSEcCtD
Scopolamine—Dizziness—Lovastatin—atherosclerosis	0.00129	0.00442	CcSEcCtD
Scopolamine—Dizziness—Ezetimibe—atherosclerosis	0.00126	0.00434	CcSEcCtD
Scopolamine—Vomiting—Lovastatin—atherosclerosis	0.00124	0.00425	CcSEcCtD
Scopolamine—Rash—Lovastatin—atherosclerosis	0.00123	0.00422	CcSEcCtD
Scopolamine—Dermatitis—Lovastatin—atherosclerosis	0.00123	0.00421	CcSEcCtD
Scopolamine—Headache—Lovastatin—atherosclerosis	0.00122	0.00419	CcSEcCtD
Scopolamine—Vomiting—Ezetimibe—atherosclerosis	0.00121	0.00417	CcSEcCtD
Scopolamine—Dizziness—Simvastatin—atherosclerosis	0.0012	0.00414	CcSEcCtD
Scopolamine—Rash—Ezetimibe—atherosclerosis	0.0012	0.00413	CcSEcCtD
Scopolamine—Dermatitis—Ezetimibe—atherosclerosis	0.0012	0.00413	CcSEcCtD
Scopolamine—Asthenia—Niacin—atherosclerosis	0.0012	0.00412	CcSEcCtD
Scopolamine—Headache—Ezetimibe—atherosclerosis	0.0012	0.00411	CcSEcCtD
Scopolamine—Pruritus—Niacin—atherosclerosis	0.00118	0.00406	CcSEcCtD
Scopolamine—Asthenia—Pravastatin—atherosclerosis	0.00118	0.00406	CcSEcCtD
Scopolamine—Pruritus—Pravastatin—atherosclerosis	0.00116	0.004	CcSEcCtD
Scopolamine—Vomiting—Simvastatin—atherosclerosis	0.00116	0.00398	CcSEcCtD
Scopolamine—Nausea—Lovastatin—atherosclerosis	0.00116	0.00397	CcSEcCtD
Scopolamine—Rash—Simvastatin—atherosclerosis	0.00115	0.00394	CcSEcCtD
Scopolamine—Dermatitis—Simvastatin—atherosclerosis	0.00115	0.00394	CcSEcCtD
Scopolamine—Headache—Simvastatin—atherosclerosis	0.00114	0.00392	CcSEcCtD
Scopolamine—Nausea—Ezetimibe—atherosclerosis	0.00113	0.0039	CcSEcCtD
Scopolamine—Dizziness—Niacin—atherosclerosis	0.0011	0.0038	CcSEcCtD
Scopolamine—Dizziness—Pravastatin—atherosclerosis	0.00109	0.00374	CcSEcCtD
Scopolamine—Nausea—Simvastatin—atherosclerosis	0.00108	0.00371	CcSEcCtD
Scopolamine—Vomiting—Niacin—atherosclerosis	0.00106	0.00365	CcSEcCtD
Scopolamine—Rash—Niacin—atherosclerosis	0.00105	0.00362	CcSEcCtD
Scopolamine—Dermatitis—Niacin—atherosclerosis	0.00105	0.00362	CcSEcCtD
Scopolamine—Headache—Niacin—atherosclerosis	0.00105	0.0036	CcSEcCtD
Scopolamine—Vomiting—Pravastatin—atherosclerosis	0.00105	0.00359	CcSEcCtD
Scopolamine—Rash—Pravastatin—atherosclerosis	0.00104	0.00356	CcSEcCtD
Scopolamine—Dermatitis—Pravastatin—atherosclerosis	0.00104	0.00356	CcSEcCtD
Scopolamine—Headache—Pravastatin—atherosclerosis	0.00103	0.00354	CcSEcCtD
Scopolamine—Nausea—Niacin—atherosclerosis	0.000992	0.00341	CcSEcCtD
Scopolamine—Nausea—Pravastatin—atherosclerosis	0.000977	0.00336	CcSEcCtD
Scopolamine—ABCB1—Metabolism—ALOX5—atherosclerosis	5.1e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	5.09e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	5.09e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	5.09e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKCG—atherosclerosis	5.07e-05	0.000211	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	5.04e-05	0.000211	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	5.04e-05	0.000211	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	5.04e-05	0.000211	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—atherosclerosis	4.93e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	4.91e-05	0.000205	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.91e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—F2—atherosclerosis	4.91e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—F2—atherosclerosis	4.89e-05	0.000204	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—F2—atherosclerosis	4.84e-05	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HMOX1—atherosclerosis	4.78e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	4.77e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	4.7e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	4.68e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGT—atherosclerosis	4.65e-05	0.000194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	4.64e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOB—atherosclerosis	4.58e-05	0.000191	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NAMPT—atherosclerosis	4.58e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	4.57e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—atherosclerosis	4.56e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LEP—atherosclerosis	4.56e-05	0.00019	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LIPC—atherosclerosis	4.55e-05	0.00019	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOC3—atherosclerosis	4.52e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CAV1—atherosclerosis	4.52e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOA1—atherosclerosis	4.51e-05	0.000188	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LDLR—atherosclerosis	4.49e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	4.49e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	4.47e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	4.46e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGT—atherosclerosis	4.46e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTM1—atherosclerosis	4.45e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	4.44e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	4.43e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	4.4e-05	0.000184	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CETP—atherosclerosis	4.39e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	4.37e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—LPL—atherosclerosis	4.37e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—atherosclerosis	4.37e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LEP—atherosclerosis	4.37e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	4.36e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ESR1—atherosclerosis	4.35e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PLG—atherosclerosis	4.35e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLG—atherosclerosis	4.33e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CAV1—atherosclerosis	4.33e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	4.32e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOA1—atherosclerosis	4.32e-05	0.00018	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.31e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—F2—atherosclerosis	4.3e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLG—atherosclerosis	4.29e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX1—atherosclerosis	4.27e-05	0.000178	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SCARB1—atherosclerosis	4.2e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ESR1—atherosclerosis	4.17e-05	0.000174	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CD36—atherosclerosis	4.15e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—F2—atherosclerosis	4.12e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	4.12e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	4.12e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	4.1e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	4.06e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	3.97e-05	0.000166	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMGCR—atherosclerosis	3.97e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	3.96e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	3.96e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	3.94e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	3.94e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	3.94e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—atherosclerosis	3.94e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	3.92e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	3.91e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—INS—atherosclerosis	3.9e-05	0.000163	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.89e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARA—atherosclerosis	3.86e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOB—atherosclerosis	3.84e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—atherosclerosis	3.83e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOB—atherosclerosis	3.83e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	3.81e-05	0.000159	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	3.8e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOB—atherosclerosis	3.79e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	3.78e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	3.77e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	3.77e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—atherosclerosis	3.77e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	3.76e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	3.75e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—atherosclerosis	3.74e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	3.74e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	3.73e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INS—atherosclerosis	3.73e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	3.7e-05	0.000155	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—atherosclerosis	3.67e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LPL—atherosclerosis	3.67e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—atherosclerosis	3.67e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LPL—atherosclerosis	3.66e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAV1—atherosclerosis	3.63e-05	0.000152	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOA1—atherosclerosis	3.62e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LPL—atherosclerosis	3.62e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—atherosclerosis	3.61e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	3.58e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	3.57e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	3.55e-05	0.000148	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ABCA1—atherosclerosis	3.54e-05	0.000148	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	3.52e-05	0.000147	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	3.47e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	3.46e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	3.46e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	3.45e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	3.43e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	3.43e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—atherosclerosis	3.42e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	3.41e-05	0.000142	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CG—atherosclerosis	3.31e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—atherosclerosis	3.27e-05	0.000136	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	3.21e-05	0.000134	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	3.2e-05	0.000134	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—atherosclerosis	3.19e-05	0.000133	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	3.17e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—atherosclerosis	3.14e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—INS—atherosclerosis	3.13e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—atherosclerosis	3.13e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—atherosclerosis	3.1e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—atherosclerosis	3.07e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—atherosclerosis	3.07e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—atherosclerosis	3.06e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—atherosclerosis	3.06e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	3.05e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	3.04e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	3.04e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—atherosclerosis	3.03e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—atherosclerosis	3.03e-05	0.000127	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—atherosclerosis	3.03e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	3.03e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	3.03e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	3.01e-05	0.000125	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	3e-05	0.000125	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	2.94e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	2.93e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	2.93e-05	0.000122	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOB—atherosclerosis	2.91e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	2.9e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—F2—atherosclerosis	2.9e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	2.9e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—F2—atherosclerosis	2.89e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—atherosclerosis	2.88e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—atherosclerosis	2.87e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—F2—atherosclerosis	2.86e-05	0.000119	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—atherosclerosis	2.83e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	2.8e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	2.77e-05	0.000116	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LPL—atherosclerosis	2.77e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	2.77e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—atherosclerosis	2.76e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—atherosclerosis	2.75e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—atherosclerosis	2.74e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	2.74e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	2.71e-05	0.000113	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—atherosclerosis	2.71e-05	0.000113	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	2.67e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	2.66e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	2.66e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	2.65e-05	0.000111	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD36—atherosclerosis	2.64e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INS—atherosclerosis	2.63e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—atherosclerosis	2.62e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	2.62e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INS—atherosclerosis	2.62e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	2.6e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INS—atherosclerosis	2.59e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	2.58e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	2.58e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	2.55e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	2.55e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	2.55e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	2.54e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	2.53e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—atherosclerosis	2.51e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	2.51e-05	0.000105	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—atherosclerosis	2.5e-05	0.000104	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	2.46e-05	0.000103	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARA—atherosclerosis	2.45e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—atherosclerosis	2.44e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	2.41e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	2.4e-05	0.0001	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	2.38e-05	9.94e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—atherosclerosis	2.37e-05	9.9e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	2.36e-05	9.83e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—atherosclerosis	2.33e-05	9.74e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	2.33e-05	9.71e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—atherosclerosis	2.33e-05	9.7e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAV1—atherosclerosis	2.3e-05	9.61e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	2.3e-05	9.61e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOA1—atherosclerosis	2.3e-05	9.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	2.3e-05	9.58e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	2.27e-05	9.49e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	2.26e-05	9.43e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	2.23e-05	9.3e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.16e-05	9.03e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.1e-05	8.76e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.04e-05	8.53e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.04e-05	8.5e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—atherosclerosis	2.03e-05	8.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.02e-05	8.42e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INS—atherosclerosis	1.99e-05	8.29e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.97e-05	8.24e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	1.97e-05	8.21e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	1.95e-05	8.13e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.94e-05	8.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.94e-05	8.08e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.92e-05	8e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.85e-05	7.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.84e-05	7.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.83e-05	7.63e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.82e-05	7.61e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.82e-05	7.6e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—atherosclerosis	1.82e-05	7.6e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.8e-05	7.53e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.8e-05	7.5e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.79e-05	7.48e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.79e-05	7.48e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.79e-05	7.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.77e-05	7.4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.77e-05	7.38e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—atherosclerosis	1.74e-05	7.27e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.7e-05	7.1e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.66e-05	6.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.65e-05	6.9e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.64e-05	6.86e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.64e-05	6.84e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.64e-05	6.83e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.63e-05	6.8e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.62e-05	6.77e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.59e-05	6.65e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.57e-05	6.55e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.57e-05	6.55e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.56e-05	6.53e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.55e-05	6.47e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.52e-05	6.36e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.52e-05	6.33e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.5e-05	6.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.5e-05	6.27e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—atherosclerosis	1.26e-05	5.27e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.15e-05	4.79e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.14e-05	4.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.13e-05	4.73e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.06e-05	4.42e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.06e-05	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.05e-05	4.36e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—atherosclerosis	8.01e-06	3.34e-05	CbGpPWpGaD
